Perpetuum Ventures
Smedenstraat 20
2610 Antwerpen
BE
Perpetuum Ventures
Foundation date
18/01/2018
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Peptides
- #Therapeutics - Proteins
- #Therapeutics - Small molecules
- #Therapeutics - Vaccines
- #Pharma - Nucleic acid drugs
Therapeutic areas
- #Cardiovascular
- #Conditions originating in the perinatal period
- #Digestive system
- #Neoplasms / cancer / oncology
- #Respiratory system
- #Skin and subcutaneous tissue
PIONEERING PLANT SCIENCE.
Perpetuum is a biotech company that develops safe, sustainable plant-based therapeutics for the effective management and improvement of healthspan of people.
Our company focuses on four R&D platforms:
Plant cell extraction
Transient expression of recombinant proteins in plants
Dendritic nano adjuvants
Biopolymer scaffolds
Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2809 '22
Neurotechnologies
Event by: VIB -
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB
Latest news
More news-
Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®
Monday August 8th 2022
Read more
-
S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities
Tuesday August 2nd 2022
Read more
-
Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial
Monday August 1st 2022
Read more
Jobs
More jobs-
10/08/22
Flemish Brabant
Laboratory Technicians in Angiogenesis and Vascular Metabolism
Permanent
VIB -
10/08/22
Flemish Brabant
Postdoctoral researcher “Microfluidic single cell sorting of circulating tumor cells”
Permanent
VIB -